Filing Details
- Accession Number:
- 0001209191-22-031236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 06:09:42
- Reporting Period:
- 2022-05-19
- Accepted Time:
- 2022-05-23 06:09:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1574094 | Renovorx Inc. | RNXT | Pharmaceutical Preparations (2834) | 271448452 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1862613 | Shaun Bagai | C/O Renovorx, Inc. 4546 El Camino Real, Suite B1 Los Altos CA 94022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-19 | 5,500 | $2.05 | 251,557 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering.